Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: Implications for active surveillance candidates selection.
about
Active surveillance for intermediate-risk prostate cancerEvaluation of the effectiveness of adding androgen deprivation to modern dose-escalated radiotherapy for men with favorable intermediate-risk prostate cancer.The risk of biochemical recurrence for intermediate-risk prostate cancer after radical prostatectomy.External validation of a nomogram for identification of pathologically favorable disease in intermediate risk prostate cancer patients.
P2860
Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: Implications for active surveillance candidates selection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Identification of pathological ...... eillance candidates selection.
@en
Identification of pathological ...... eillance candidates selection.
@nl
type
label
Identification of pathological ...... eillance candidates selection.
@en
Identification of pathological ...... eillance candidates selection.
@nl
prefLabel
Identification of pathological ...... eillance candidates selection.
@en
Identification of pathological ...... eillance candidates selection.
@nl
P2093
P2860
P356
P1433
P1476
Identification of pathological ...... eillance candidates selection.
@en
P2093
Felix K H Chun
Francesco Montorsi
Giorgio Gandaglia
Jonas Schiffmann
Marco Moschini
Markus Graefen
Nazareno Suardi
Thorsten Schlomm
P2860
P304
P356
10.1002/PROS.23040
P577
2015-07-14T00:00:00Z